Cracking the case

Journal of Hospital Medicine

Volumn 6, Issue 8, 2011, Pages 480-484

  Wei, Jennie ^a   Kneeland, Patrick P ^b   Dhaliwal, Gurpreet ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Providence Regional Medical Center   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; HYDROMORPHONE; LEVAMISOLE; PREDNISONE;

ADULT; AMYLOID PLAQUE; ANKLE INJURY; ARTHRALGIA; CASE REPORT; ERYTHEMA NODOSUM; FATIGUE; FEMALE; HUMAN; JOINT SWELLING; NOTE; PRIORITY JOURNAL; SKIN BIOPSY; SKIN BLOOD VESSEL DISORDER; SKIN DEFECT; SKIN ULCER; VASCULITIS; CHEMICALLY INDUCED DISORDER; DRUG TOXICITY; NEUTROPENIA; PURPURA; REVIEW; URINE;

ADULT; DRUG TOXICITY; FEMALE; HUMANS; LEVAMISOLE; NEUTROPENIA; PURPURA;

EID: 84856611706     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.902     Document Type: Note

References (16)

1. Amery WK, Bruynseels JP. Levamisole, the story and the lessons. Int J Immunopharmocol. 1992; 14( 3): 481-486.
2. British Association for Paediatric Nephrology. Levamisole for corticosteroid-dependent nephrotic syndrome in childhood. Lancet. 1991; 337: 1555-1557.
3. Quirt I, Shelley W, Pater J, Bodurtha A, McCulloch P. Improved survival in patients with poor-prognosis malignant melanoma treated with adjuvant levamisole: a phase III study by the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol. 1991; 9: 729-735.
4. Moertel CG, Fleming TR, MacDonald JS. Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med. 1990; 322: 352-358.
5. Thompson JS, Herbick JM, Klassen LW. Studies on levamisole-induced agranulocytosis. Blood. 1980; 56( 3): 388-396.
6. Rongioletti F, Ghio L, Ginevri F. Purpura of the ears: a distinctive vasculopathy with circulating autoantibodies complicating long-term treatment with levamisole in children. Br J Dermatol. 1999; 140: 948-951.
7. Frederick J. Janssen Discontinues Ergamisol. Available at: Accessed July 25, 2010.
8. SAMHSA. Nationwide Public Health Alert Issued Concerning Life-Threatening Risk Posed by Cocaine Laced with Veterinary Anti-Parasite Drug. Available at: Accessed July 20, 2010.
9. Fucci N. Unusual adulterants in cocaine seized on Italian clandestine market. Forensic Sci Int. 2007; 172( 2-3): e1.
10. Buchanan JA, Vogel JA, Eberhardt AM. Levamisole-induced occlusive necrotizing vasculitis of the ears after use of cocaine contaminated with levamisole. J Med Toxicol. 2010;Jun 12.
11. Bradford M, Rosenberg B, Moreno J, Dumyati G. Bilateral necrosis of earlobes and cheeks: another complication of cocaine contaminated with levamisole. Ann Intern Med. 2010;1; 152( 11): 758-759.
12. Waller JM, Feramisco JD, Alberta-Wszolek L, McCalmont TH, Fox LP. Cocaine-associated retiform purpura and neutropenia: is levamisole the culprit? J Am Acad Dermatol. 2010;Mar 19.
13. Buchanan JA, Oyer RJ, Patel NR, Jacquet GA. A confirmed case of agranulocytosis after use of cocaine contaminated with levamisole. J Med Toxicol. 2010;Apr 1.
14. Centers for Disease Control and Prevention. Agranulocytosis associated with cocaine use-four States, March 2008-November 2009. MMWR. 2009; 58( 49): 1381-1385.
15. Morley SR, Forrest AR, Galloway JH. Levamisole as a contaminant of illicit cocaine. Journal of the Clandestine Laboratory Investigating Chemists Association. 2006; 16: 6-11. Available at: Accessed July 20, 2010.
16. LeGatt DF. Cocaine Cutting Agents-A Discussion. Laboratory Medicine and Pathology, University of Alberta. Available at: Accessed July 20, 2010.